To study whether m6A modification of the CEBPB mRNA contributes to its translational regulation, we applied FTO knockdown (shFTO) in triple‐negative MDA‐MB‐231 and luminal A‐type MCF‐7 breast cancer cell lines, and mouse embryonic fibroblasts (MEFs). This evidence concerns the gene FTO and breast cancer.